Two stable gut microbiome guilds predict liver tumor class and treatment responses
iMeta · 2026-04 · 5 (2)
DOI: 10.1002/imt2.70123 ↗Kurz gefasst
Fachartikel in der Zeitschrift iMeta, online erschienen am 02.04.2026. Verfasst von Yang Liu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery Division, Ningbo No. 2 Hospital Wenzhou Medical University Ningbo China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Gut microbiome alterations are increasingly associated with hepatocellular carcinoma (HCC), highlighting the gut–liver axis as a key contributor to tumor progression and prognosis. Taxon‐based HCC microbiome studies have shown limited reproducibility because they are affected by database dependency, taxonomic ambiguity, and overlooked ecological interactions. The Two Competing Guilds (TCG) model, based on stable gut microbiome interactions, provides a structurally grounded framework for robust, generalizable biomarkers. Using shotgun metagenomic data from a newly recruited cohort of 120 surgically resectable HCC cases and 76 benign liver tumor controls, we constructed co‐abundance networks to identify stably correlated genome pairs and assembled a hepatic cancer‐TCG (HCC‐TCG) model composed of 142 genomes. Functionally, one Guild had more genes for butyrate production from carbohydrate fermentation while the other Guild was enriched in genes for virulence factors and antibiotic resistance, highlighting its potential proinflammatory roles. Classifiers trained on the abundance profiles of HCC‐TCG genomes successfully distinguished HCC from benign liver tumors (area under the receiver operating characteristic, AUROC = 0.70) and from colorectal liver metastases (CRLM) (AUROC = 0.78). In an external validation cohort, the model further discriminated against HCC from intrahepatic cholangiocarcinoma (iCCA) (AUROC = 0.72), and from healthy controls (AUROC = 0.79–0.85), demonstrating its broad applicability for tumor stratification across clinical contexts. Moreover, HCC‐TCG profiles predicted post‐resection recurrence risk and response to adjuvant therapies (AUROC up to 0.83). Importantly, external validation in two independent cohorts of advanced HCC patients treated with PD‐1/PD‐L1 inhibitors demonstrated consistent predictive performance (AUROC = 0.64–0.73), confirming the model's generalizability in nonsurgical and immunotherapy contexts. This genome‐specific, ecologically structured, and database‐independent framework identifies a conserved Guild‐based microbiome signature for HCC. Our findings demonstrate that a fixed genome‐resolved ecological structure retains transferable discriminatory signal across clinical contexts. The HCC‐TCG framework provides a genome‐specific, interaction‐based foundation for future development of non‐invasive microbiome stratification strategies requiring prospective validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery Division, Ningbo No. 2 Hospital Wenzhou Medical University Ningbo China.
- Ningbo Key Laboratory of Intestinal Microecology and Human Major Diseases Ningbo China.
- Department of Hepatobiliary Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education Shanghai China.
- Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences and Center for Microbiome, Nutrition, and Health, New Jersey Institute for Food, Nutrition, and Health, Rutgers The State Univ…
- Rutgers-Jiaotong Joint Laboratory for Microbiome and Human Health New Brunswick New Jersey USA.
- State Key Laboratory of Microbial Metabolism and Ministry of Education Key Laboratory of Systems Biomedicine, School of Life Sciences and Biotechnology Shanghai Jiao Tong University Shanghai China.
ORCID-Profile: Yang Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Zhang, Z., Wu, G., Li, B., Wang, L., Wang, J., Wei, Z., Wang, Z., Yang, J., Zhang, K., Zhang, T., Tao, X., Chen, T., Fan, J., Zhou, J., Yang, X., Zhao, L., & Wei, Y. (2026). Two stable gut microbiome guilds predict liver tumor class and treatment responses. iMeta, 5(2). https://doi.org/10.1002/imt2.70123
Vancouver
Liu Y, Zhang Z, Wu G, Li B, Wang L, Wang J, et al. Two stable gut microbiome guilds predict liver tumor class and treatment responses. iMeta. 2026;5(2). doi:10.1002/imt2.70123
BibTeX
@article{Liu2026,
author = {Liu, Yang and Zhang, Zefan and Wu, Guojun and Li, Bowen and Wang, Linghua and Wang, Jincheng and Wei, Zixian and Wang, Zhiyue and Yang, Jinhua and Zhang, Kunyu and Zhang, Tianqi and Tao, Xin and Chen, Tao and Fan, Jia and Zhou, Jian and Yang, Xinrong and Zhao, Liping and Wei, Yunwei},
title = {Two stable gut microbiome guilds predict liver tumor class and treatment responses},
journal = {iMeta},
year = {2026},
volume = {5},
number = {2},
doi = {10.1002/imt2.70123}
}
EUVIMED